Accelerant Holdings

Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers

Aroa Biosurgery announced positive results from a 143-patient, 10-site U.S. randomized controlled trial of Symphony in diabetic foot ulcers, published in the International Wound Journal. Complete wound closure at 12 weeks was 55% with Symphony plus standard of care versus 35% with standard of care alone (p=0.039), and mean healing time fell by 7.8 days (65.4 vs 73.2 days, p=0.041). CEO Brian Ward called the publication a major milestone, saying Level I evidence strengthens Symphony's differentiation and commercial value as payors increasingly demand robust RCT data.

•1mo ago

Shell completes acquisition of ARC Resources

Shell plc has completed its acquisition of ARC Resources Ltd. (TSX: ARX), effective September 2, 2026, following receipt of all required shareholder, court and regulatory approvals. ARC shareholders will receive CAD $8.20 in cash plus 0.40247 Shell plc shares for each ARC common share, equating to an updated equity value of approximately US$13.9 billion and an enterprise value of approximately US$16.5 billion after about US$2.5 billion of assumed net debt and leases. The equity value is funded with US$3.3 billion in cash and US$10.6 billion in new Shell shares. The deal adds approximately 370 kboe/d of production across liquids and gas in Canada's Montney basin, supports a production CAGR of around 4% through 2030 versus 2025, and is expected by Shell to generate double-digit returns and be accretive to free cash flow per share from 2027 onwards. Delivery of Shell shares to ARC holders is anticipated several days after the effective date, after which ARX ceases to trade as an independent listing.

•2mo ago

AM Best Places Credit Ratings of Accelerant Holdings’ Rated Subsidiaries Under Review With Developing Implications

AM Best placed the credit ratings of Accelerant Holdings' subsidiaries under review with developing implications following the announcement of a definitive agreement to be acquired by Thoma Bravo. Under the terms of the agreement, Accelerant Class A and Class B shareholders will receive $20.25 per share in cash, with a 6% ticking fee accruing annually if the closing is delayed by regulatory approvals. Upon completion of the transaction, Accelerant will become a privately held company and its common shares will be delisted from the NYSE.

•2mo ago

Accelerant Announces Second Quarter 2026 Results

Accelerant announced a definitive agreement to be acquired by Thoma Bravo, a move that will take the company private. The deal comes alongside strong Q2 results, featuring a 23% year-over-year increase in Exchange Written Premium to $1.32 billion and a 165% surge in adjusted net income. Adjusted EBITDA grew 47% to $93.1 million with an improved margin of 30.6%, while the company actively returned capital by repurchasing 4.7 million shares for $66 million. Due to the pending transaction, Accelerant canceled its earnings conference call and withdrew guidance for the remainder of the year.

•2mo ago

Accelerant Enters into Definitive Agreement to be Acquired by Thoma Bravo

Accelerant has agreed to be acquired by Thoma Bravo in an all-cash transaction valued at more than $4 billion, with shareholders receiving $20.25 per share. The purchase price represents a 49% premium to Accelerant’s closing share price on August 12, 2026, and the deal is expected to close in the first half of 2027. Altamont Capital Partners, which holds approximately 82% of the outstanding voting rights, has agreed to vote in favor of the transaction, which is not subject to any financing condition.

•2mo ago

Accelerant Announces Partnership With New Third-Party Capitalized Insurer WoodStar

Accelerant (ARX) partnered with newly formed WoodStar Reciprocal Exchange, a third-party capitalized insurer funded with over $220 million from Kilter Finance and Blue Owl Capital. WoodStar received an AM Best “A -” rating and will provide dedicated underwriting capacity exclusively on the Accelerant Risk Exchange, managed by an attorney-in-fact majority-owned by Accelerant. The partnership is expected to begin writing meaningful direct business in 2027, reinforcing Accelerant's strategy to link institutional capital with specialty insurance risk.

•3mo ago

Accelerant Announces Enhanced Lloyd’s Partnership with the Launch of the ARX Consortium

Accelerant announced an enhanced partnership with Lloyd’s of London marked by the launch of the ARX Consortium, which is backed by seven Lloyd’s syndicates. The initiative establishes a flexible platform that combines Accelerant's premium flow with Lloyd's market reputation to support a diversified specialty risk portfolio. CEO Jeff Radke highlighted the opportunity to drive profitable growth for Lloyd’s through Accelerant's expanding group of MGA Members.

•4mo ago

Incline P&C Group Announces Enhanced Partnership with Accelerant

Incline P&C Group has expanded its partnership with Accelerant to serve as a fronting carrier for more than $500 million in annual gross written premiums. The enhanced agreement, effective July 1, increases Incline's participation in Accelerant's portfolio and provides direct reinsurance access to Accelerant's Risk Capital Partners. Accelerant CEO Jeff Radke noted that the partnership positions the MGA Member base for continued profitable growth within the specialty insurance ecosystem.

•4mo ago

Hippo Holdings Announces Enhanced Partnership with Accelerant to Expand Access to the Specialty Insurance Market

Hippo Holdings announced an enhanced partnership with Accelerant to serve as a fronting carrier for more than $500 million in annual gross written premiums across Accelerant's U.S. portfolio effective July 1. Accelerant CEO Jeff Radke noted the partnership strengthens the Risk Exchange and provides MGAs continued runway for profitable growth. Hippo cited the agreement as a driver for pulling forward its $2 billion GWP target to 2027 and raising its 2028 guidance.

•4mo ago

FutureProof Launches an AI E&S Program with Bridge Specialty Group to Target Condo and Renters Policies in Catastrophe-Exposed Southeast

FutureProof Technologies has launched a new AI-powered excess and surplus lines insurance program for condo and renters policies in catastrophe-exposed states like Florida and Texas. The program is a partnership with Bridge Specialty Group, which will provide distribution and carrier capacity, and Accelerant (NYSE: ARX), which will provide risk exchange capacity and data analytics infrastructure. FutureProof has written over $1 billion in total insurable value since its launch in August 2024, demonstrating the scale of market need for its AI-driven underwriting approach.

•5mo ago